Literature DB >> 3567035

Post-marketing surveillance in the UK (1984).

D H Lawson.   

Abstract

Mesh:

Year:  1986        PMID: 3567035      PMCID: PMC1401005          DOI: 10.1111/j.1365-2125.1986.tb02986.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

1.  Post-marketing surveillance of adverse reactions to new medicines.

Authors:  A B Wilson
Journal:  Br Med J       Date:  1977-10-15

2.  Methodology of monitored release of a new preparation: buprenorphine.

Authors:  A W Harcus; A E Ward; D W Smith
Journal:  Br Med J       Date:  1979-07-21

3.  The role of record linkage in post-marketing drug surveillance.

Authors:  I K Crombie
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

4.  Monitoring adverse reactions to new drugs: "restricted release" or "monitored release"?

Authors:  D H Lawson; D A Henry
Journal:  Br Med J       Date:  1977-03-12

5.  Monitoring adverse reactions to drugs.

Authors:  C T Dollery; M D Rawlins
Journal:  Br Med J       Date:  1977-01-08

6.  Postmarketing surveillance of adverse reactions to drugs.

Authors:  M D Rawlins
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-24

7.  Double standards, scientific methods, and epidemiologic research.

Authors:  A R Feinstein; R I Horwitz
Journal:  N Engl J Med       Date:  1982-12-23       Impact factor: 91.245

8.  Postmarketing surveillance: practical experience with ketotifen.

Authors:  W P Maclay; D Crowder; S Spiro; P Turner
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-24

9.  Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study.

Authors:  D G Colin-Jones; M J Langman; D H Lawson; M P Vessey
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-06

10.  Postmarketing surveillance of the safety of cimetidine: 12 month mortality report.

Authors:  D G Colin-Jones; M J Langman; D H Lawson; M P Vessey
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.